Detalles de la búsqueda
1.
Pitavastatin treatment remodels the HDL subclass lipidome and proteome in hypertriglyceridemia.
J Lipid Res
; 65(2): 100494, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160756
2.
Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
Curr Opin Lipidol
; 33(3): 199-207, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695616
3.
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
Eur Heart J
; 42(47): 4791-4806, 2021 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472586
4.
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Circulation
; 141(8): 624-636, 2020 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707832
5.
Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.
Eur Heart J
; 41(24): 2304-2312, 2020 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872245
6.
Remnant lipoproteins: are they equal to or more atherogenic than LDL?
Curr Opin Lipidol
; 31(3): 132-139, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32332433
7.
LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL.
J Lipid Res
; 61(6): 911-932, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32295829
8.
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Clin Chem Lab Med
; 58(4): 496-517, 2020 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31855562
9.
Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap.
Eur Heart J Suppl
; 22(Suppl J): J21-J33, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33061865
10.
Beyond cardiovascular medicine: potential future uses of icosapent ethyl.
Eur Heart J Suppl
; 22(Suppl J): J54-J64, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33061868
11.
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.
N Engl J Med
; 375(22): 2144-2153, 2016 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27959767
12.
No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data.
Eur Heart J
; 39(5): 374-381, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29186504
13.
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.
Eur Heart J
; 39(27): 2526-2539, 2018 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29718253
14.
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
JAMA
; 321(4): 364-373, 2019 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30694319
15.
Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate.
J Lipid Res
; 59(1): 25-34, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29150495
16.
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.
Clin Chem
; 64(7): 1006-1033, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29760220
17.
Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.
Circ Res
; 119(6): 751-63, 2016 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27436846
18.
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Eur Heart J
; 38(32): 2459-2472, 2017 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28444290
19.
Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Biochim Biophys Acta Mol Cell Biol Lipids
; 1862(9): 890-900, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28529180
20.
Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c.
Biochim Biophys Acta Mol Cell Biol Lipids
; 1862(2): 188-195, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815221